SHY: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

July 16, 2020

Subjects will vary for each presentation within the series. In general, each presentation will review current pharmacotherapeutic management recommendation for a given disease state. The goal of the series is to ensure that our pharmacists practice consistent, evidence-based pharmacy.

 

 

Target Audience

The target audience consists of pharmacists, pharmacy residents, and pharmacy students

Learning Objectives

 

  • Offer structured support of professional development for pharmacists
  • Incentivize pharmacists to engage in professional development sessions by providing continuing education credit for attendance
  • Review current pharmacotherapeutic management recommendations for various disease states Emphasize knowledge gained during presentations through summary slides, questions and/or patient cases
  • Ensure that residency preceptors are aware of current evidence-based pharmacy recommendations

 

  • Describe the unique pharmacologic properties of andexanet alfa
  • Review evidence-based literature for andexanet alfa and its role in clinical practice
  • Identify patients who are candidates to receive reversal with andexanet alfa
  • Address pharmacoeconomic concerns about the use of andexanet alfa

 

 

Course summary
Available credit: 
  • 0.50 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 0.50 Attendance
Course opens: 
07/16/2020
Course expires: 
09/16/2020
Event starts: 
07/16/2020 - 12:30pm
Event ends: 
07/16/2020 - 1:00pm

Subjects will vary for each presentation within the series. In general, each presentation will review current pharmacotherapeutic management recommendation for a given disease state. The goal of the series is to ensure that our pharmacists practice consistent, evidence-based pharmacy.

Shadyside Hospital
Pittsburgh, PA
United States

EUNICE BOO, PHARMD, BCCCP

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This knowledge-based activity provides .5 contact hours of continuing pharmacy education credit.

The assigned universal program number(s) is:  JA4008223-0000-20-046-L04-P

 

Available Credit

  • 0.50 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 0.50 Attendance
Please login or register to take this course.

Registration is complimentary and pre-registration is not required.